| __timestamp | Corcept Therapeutics Incorporated | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 882000 | 205018000 |
| Thursday, January 1, 2015 | 1361000 | 392709000 |
| Friday, January 1, 2016 | 2058000 | 299694000 |
| Sunday, January 1, 2017 | 3554000 | 397061000 |
| Monday, January 1, 2018 | 5215000 | 434100000 |
| Tuesday, January 1, 2019 | 5504000 | 782200000 |
| Wednesday, January 1, 2020 | 5582000 | 1119900000 |
| Friday, January 1, 2021 | 5281000 | 2437500000 |
| Saturday, January 1, 2022 | 5385000 | 1560400000 |
| Sunday, January 1, 2023 | 6481000 | 1815800000 |
| Monday, January 1, 2024 | 1970500000 |
Cracking the code
In the competitive world of biotechnology, understanding cost structures is crucial. Regeneron Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated, two prominent players, have shown distinct financial trajectories over the past decade. From 2014 to 2023, Regeneron's cost of revenue surged by approximately 785%, reflecting its aggressive expansion and increased production capabilities. In contrast, Corcept's cost of revenue grew by about 635%, indicating a steady yet significant rise in operational expenses.
Regeneron's peak in 2021, with costs reaching nearly $2.44 billion, underscores its rapid scaling and market penetration. Meanwhile, Corcept's consistent growth, culminating in a 2023 cost of $6.48 million, highlights its strategic focus on niche markets. These trends not only reveal the companies' financial strategies but also provide insights into the broader biotech industry's evolution.
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc.
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Lantheus Holdings, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Perrigo Company plc's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Regeneron Pharmaceuticals, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Catalent, Inc. vs Corcept Therapeutics Incorporated
Cost of Revenue Trends: Grifols, S.A. vs Corcept Therapeutics Incorporated
Comparing Cost of Revenue Efficiency: Corcept Therapeutics Incorporated vs Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Corcept Therapeutics Incorporated and Telix Pharmaceuticals Limited
Cost of Revenue Trends: Corcept Therapeutics Incorporated vs MorphoSys AG
Cost of Revenue Comparison: Corcept Therapeutics Incorporated vs Vericel Corporation
Analyzing Cost of Revenue: Corcept Therapeutics Incorporated and Mesoblast Limited